Central Pharmaceutical JSC No3
Central Pharmaceutical JSC No3 operates in Pharmaceuticals.
Market Cap & Net Worth: Central Pharmaceutical JSC No3 (DP3)
Central Pharmaceutical JSC No3 (VN:DP3) has a market capitalization of $22.99K (₫584.18 Million) as of March 18, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #43611 globally and #329 in its home market, demonstrating a -0.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Central Pharmaceutical JSC No3's stock price ₫62600.00 by its total outstanding shares 9332 (9.33K).
Central Pharmaceutical JSC No3 Market Cap History: 2015 to 2026
Central Pharmaceutical JSC No3's market capitalization history from 2015 to 2026. Data shows growth from $1.49K to $22.99K (29.35% CAGR).
Index Memberships
Central Pharmaceutical JSC No3 is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
HNX
HNXI
|
$1.88 Million | 1.19% | #16 of 302 |
|
HNX Large Cap
HNXLC
|
$441.93K | 5.08% | #6 of 49 |
Weight: Central Pharmaceutical JSC No3's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Central Pharmaceutical JSC No3 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Central Pharmaceutical JSC No3's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DP3 by Market Capitalization
Companies near Central Pharmaceutical JSC No3 in the global market cap rankings as of March 18, 2026.
Key companies related to Central Pharmaceutical JSC No3 by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3469 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #5585 globally with a market cap of $1.61 Billion USD ( ₩2.36 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7048 globally with a market cap of $1.07 Billion USD ( ₩1.56 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7477 globally with a market cap of $962.14 Million USD ( ₩1.41 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3469 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩730000.00 |
| #5585 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.61 Billion | ₩113500.00 |
| #7048 | ST Pharm Co.Ltd | KQ:237690 | $1.07 Billion | ₩155100.00 |
| #7477 | Oscotec Inc | KQ:039200 | $962.14 Million | ₩59300.00 |
Central Pharmaceutical JSC No3 Historical Marketcap From 2015 to 2026
Between 2015 and today, Central Pharmaceutical JSC No3's market cap moved from $1.49K to $ 22.99K, with a yearly change of 29.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₫22.99K | +18.56% |
| 2025 | ₫19.39K | -9.43% |
| 2024 | ₫21.41K | -7.15% |
| 2023 | ₫23.06K | +88.81% |
| 2022 | ₫12.21K | -12.28% |
| 2021 | ₫13.92K | +37.87% |
| 2020 | ₫10.10K | +28.10% |
| 2019 | ₫7.88K | +0.16% |
| 2018 | ₫7.87K | +18.33% |
| 2017 | ₫6.65K | +159.87% |
| 2016 | ₫2.56K | +72.19% |
| 2015 | ₫1.49K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Central Pharmaceutical JSC No3 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $22.99K USD |
| MoneyControl | $22.99K USD |
| MarketWatch | $22.99K USD |
| marketcap.company | $22.99K USD |
| Reuters | $22.99K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.